Alexandra Valenti

Alexandra Valenti

Goodwin

Contact
View Bio
RSS

Latest Posts › Celltrion

Share:

Health Canada Approves Celltrion’s Adalimumab Biosimilar, YUFLYMA

According to various reports, Celltrion has received approval from Health Canada for YUFLYMA, a biosimilar of AbbVie’s HUMIRA product.  YUFLYMA was previously approved in Europe, and is a high-concentration, low-volume,...more

1/4/2022  /  Biosimilars , Canada , Celltrion , Health Canada , Pharmaceutical Industry , Prescription Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide